Compound class:
Synthetic organic
Comment: SRI37892 is a small-molecule that was identified as a FZD7 antagonist in a reporter assay screen, but its pharmacology remains to be fully validated [1].
|
|
References |
1. Zhang W, Lu W, Ananthan S, Suto MJ, Li Y. (2017)
Discovery of novel frizzled-7 inhibitors by targeting the receptor's transmembrane domain. Oncotarget, 8 (53): 91459-91470. [PMID:29207657] |